PLRX
Price
$13.22
Change
-$0.08 (-0.60%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
SVRA
Price
$3.25
Change
+$0.02 (+0.62%)
Updated
Dec 20, 04:59 PM (EDT)
81 days until earnings call
Ad is loading...

PLRX vs SVRA

Header iconPLRX vs SVRA Comparison
Open Charts PLRX vs SVRABanner chart's image
Pliant Therapeutics
Price$13.22
Change-$0.08 (-0.60%)
Volume$82.26K
CapitalizationN/A
Savara
Price$3.25
Change+$0.02 (+0.62%)
Volume$46.47K
CapitalizationN/A
PLRX vs SVRA Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. SVRA commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and SVRA is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (PLRX: $13.21 vs. SVRA: $3.23)
Brand notoriety: PLRX and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 359% vs. SVRA: 139%
Market capitalization -- PLRX: $804.48M vs. SVRA: $556.05M
PLRX [@Biotechnology] is valued at $804.48M. SVRA’s [@Biotechnology] market capitalization is $556.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, PLRX is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 4 bullish, 7 bearish.
  • SVRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а -0.68% price change this week, while SVRA (@Biotechnology) price change was +0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

PLRX is expected to report earnings on Mar 04, 2025.

SVRA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($804M) has a higher market cap than SVRA($556M). PLRX YTD gains are higher at: -27.057 vs. SVRA (-31.277). SVRA has higher annual earnings (EBITDA): -88.58M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. SVRA (219M). SVRA has less debt than PLRX: SVRA (26.7M) vs PLRX (60.2M). PLRX (0) and SVRA (0) have equivalent revenues.
PLRXSVRAPLRX / SVRA
Capitalization804M556M145%
EBITDA-197.04M-88.58M222%
Gain YTD-27.057-31.27787%
P/E RatioN/AN/A-
Revenue00-
Total Cash405M219M185%
Total Debt60.2M26.7M225%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXSVRA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 5 days ago
71%
N/A
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRCX38.660.44
+1.15%
PGIM Jennison Natural Resources C
JSPIX24.590.26
+1.07%
Jackson Square Large-Cap Growth Instl
PMJIX11.530.06
+0.52%
PIMCO RAE US Small Instl
HEMTX9.350.03
+0.32%
Janus Henderson Emerging Markets T
FKMCX42.78-0.90
-2.06%
Fidelity Mid-Cap Stock K

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.68%
NTLA - PLRX
52%
Loosely correlated
+0.83%
RCKT - PLRX
50%
Loosely correlated
+1.85%
CRSP - PLRX
50%
Loosely correlated
+0.83%
BEAM - PLRX
50%
Loosely correlated
+8.04%
PRME - PLRX
49%
Loosely correlated
+3.94%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
N/A
LRMR - SVRA
39%
Loosely correlated
+0.75%
XENE - SVRA
39%
Loosely correlated
-0.69%
KYMR - SVRA
37%
Loosely correlated
+3.88%
ABSI - SVRA
37%
Loosely correlated
+2.40%
PLRX - SVRA
37%
Loosely correlated
-0.68%
More